UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2025
Commission File Number: 001-32371
SINOVAC BIOTECH LTD.
No. 39 Shangdi Xi Rd, Haidian District
Beijing 100085, People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
Form 20-F x
Form 40-F ¨
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
SINOVAC BIOTECH LTD. |
| |
|
|
| |
By: |
/s/ Chiang Li |
| |
Name: |
Dr. Chiang Li |
| |
Title: |
Chairman of the Board of Directors |
Date: June 30, 2025
Exhibit Index
| Exhibit 99.1 |
|
Press Release – SINOVAC Board of Directors Urges Shareholders to Vote the WHITE Proxy Card “AGAINST” the Misguided Proposals to Remove SINOVAC’s Current Board |
| |
|
|
| Exhibit 99.2 |
|
Press Release – SINOVAC Board of Directors Prevails Against Advantech/Prime’s Lawsuit in Hong Kong |
| |
|
|
| Exhibit 99.3 |
|
Press Release – SINOVAC Board of Directors Prevails Against Advantech/Prime’s New York Lawsuit |
